Research peptide · GH axis research
PEG-MGF
Also known as pegylated mechano growth factor · pegylated IGF-1Ec E-domain peptide
A polyethylene glycol conjugate of the C-terminal E-domain peptide of an insulin-like growth factor 1 splice variant. No reference structure or mass has been published for the conjugate.
- Compound type
- Research peptide
- Research area
- GH axis
What it is
PEG-MGF is a conjugate rather than a single defined molecule. The peptide part corresponds to the C-terminal E-domain of a splice variant of insulin-like growth factor 1, the variant known as IGF-1Ec, and that peptide is referred to in the literature as mechano growth factor 1. The conjugate attaches one or more polyethylene glycol chains to that peptide.
It has no PubChem entry, no published molecular formula and no reference mass, and none was located in the published literature.
Structure and chemistry
Two things follow from the construction. First, polyethylene glycol is a polymer, supplied as a distribution of chain lengths rather than a single species, so a conjugate has an average mass and a distribution rather than one exact mass. A nominal figure such as 5 kDa or 20 kDa describes the center of that distribution.
Second, the attachment site determines what the product is. The polymer is commonly coupled through an N-terminal amine, a lysine side-chain amine or a cysteine thiol, and each route gives a different regiochemistry, number of chains and degree of heterogeneity. Because no published characterization specifies the chemistry used here, two preparations with the same name need not be the same material.
How it is studied in the laboratory
Published work addresses the unconjugated peptide rather than the conjugate. A 2014 study tested synthetic mechano growth factor peptides on C2C12 cells and on primary myoblast cultures, with proliferation and differentiation assays as the readouts, and reported no detectable effect in the systems examined 1.
Analytical work exists as well. A 2014 study characterized a biotechnologically produced full-length version by mass spectrometry, establishing the mass and fragment signatures used to recognize it 2, and a 2017 study examined the in vitro metabolism of a related analog in plasma and liver preparations 3. No published study characterizes the pegylated form itself.
Analytical notes
A polymer conjugate behaves differently from a peptide in routine assays. Electrospray mass spectrometry gives a broad envelope of peaks spaced 44 mass apart, one for each ethylene oxide repeat, rather than the sharp charge series of a defined peptide, so the useful outputs are an average mass and a polydispersity figure.
Size-exclusion chromatography separates conjugated from unconjugated peptide and from free polymer, and proton NMR quantifies polymer content against peptide signals. The peptide part is best confirmed by enzymatic digestion and peptide mapping. Reversed-phase HPLC alone is a weak identity test, because the polymer dominates retention and broadens the peak.
Storage and handling in the laboratory
As supplied, the material is a lyophilized powder, stored at -20 degrees Celsius, sealed and protected from light. The lyophilized state is hygroscopic, so a sealed vial should reach room temperature before opening. Polymer chains take up water readily and can form peroxides on long storage in air, so dry, sealed storage matters more for a conjugate than for a peptide alone.
Open questions in the literature
The first gap is definitional: with no published structure, formula, attachment chemistry or mass distribution, the identity of material carrying this name cannot be verified against a reference. The second is biological: the one cell-culture study of the unconjugated peptide reported no detectable effect in the systems tested 1, and no published study has characterized the conjugate in any model.
References
- Fornaro M, Hinken AC, Needle S, et al. Endocrinology and Metabolism. 2014;306(2):E150-E156. doi:10.1152/ajpendo.00408.2013. Source
- Thevis M, Thomas A, Geyer H, Schanzer W. Growth Hormone and IGF Research. 2014;24(6):276-280. doi:10.1016/j.ghir.2014.10.004. Source
- Cox HD, Miller GD, Eichner D. Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H. Drug Testing and Analysis. 2017;9(10):1490-1498. doi:10.1002/dta.2152. Source
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.
